Sign In
Get Clay Free →

Suggestions

    Robyn Schlicher, Ph.D

    Co-founder & CEO novel platform to determine immune status | CHIEF | ODH1

    Robyn Schlicher, Ph.D. is a business development and marketing leader with a background in bioengineering. She currently holds the position of Member at Chief, which she started in June 2023.3

    Professional Background

    Dr. Schlicher earned her Ph.D. in Bioengineering from the Georgia Institute of Technology.12 Her doctoral research focused on the "Mechanism of Ultrasound-Mediated Bioeffects," which she completed in 2005.1

    Career Highlights

    Throughout her career, Dr. Schlicher has gained expertise in several areas:

    • Medical diagnostics
    • Laboratory techniques
    • Quantitative PCR (qPCR)
    • Public speaking
    • Cell biology5

    She has over a decade of experience in the biotech and pharmaceutical industries, with a focus on novel diagnostics, biomarkers, and targeted therapies.6

    Recent Positions

    Before joining Chief, Dr. Schlicher held notable positions in various companies:

    1. Pear Bio: She led corporate strategy for business development.4
    2. Genialis: In June 2021, she joined as Director of Business Development & Strategy.7

    Dr. Schlicher's work primarily involves structuring complex business concepts, particularly in the fields of bioengineering and precision medicine.4

    Highlights

    Jun 17 · genialis.com
    Genialis Expands Support for Clinical Biomarker Discovery Platform

    Related Questions

    What are Robyn Schlicher's main responsibilities at Chief?
    How did Robyn Schlicher transition from bioengineering to business development?
    What are some notable projects Robyn Schlicher has led at Pear Bio?
    How has Robyn Schlicher's work impacted the field of bioengineering?
    What is Robyn Schlicher's educational background?